Selected research
Market Structure
Global Finasteride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Finasteride market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Finasteride include Teva Pharmaceuticals, Sandoz, Shandong Renhetang Pharmaceutical, Merck, Zhejiang CONBA Pharmaceutical, Henan Topfond, Guangdong Eashu Pharmacetical, RelonChem and Dr. Reddy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Finasteride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Finasteride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Finasteride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Finasteride market size, projected growth trends, production technologies, key applications, and end-use industries.
Finasteride Segment by Company
Teva Pharmaceuticals
Sandoz
Shandong Renhetang Pharmaceutical
Merck
Zhejiang CONBA Pharmaceutical
Henan Topfond
Guangdong Eashu Pharmacetical
RelonChem
Dr. Reddy
Cipla
Actavis
Accord Pharmaceuticals
Finasteride Segment by Type
1mg Tablet
5mg Tablet
Finasteride Segment by Application
Medical Uses
Application 2
Finasteride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Finasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Finasteride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg Tablet
- 5mg Tablet
Applications
- Medical Uses
- Application 2
Companies covered
- Teva Pharmaceuticals
- Sandoz
- Shandong Renhetang Pharmaceutical
- Merck
- Zhejiang CONBA Pharmaceutical
- Henan Topfond
- Guangdong Eashu Pharmacetical
- RelonChem
- Dr. Reddy
- Cipla
- Actavis
- Accord Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Finasteride Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Finasteride Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Finasteride Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Finasteride Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Finasteride Market Dynamics
- 2.1 Finasteride Industry Trends
- 2.2 Finasteride Industry Drivers
- 2.3 Finasteride Industry Opportunities and Challenges
- 2.4 Finasteride Industry Restraints
3 Finasteride Market by Manufacturers
- 3.1 Global Finasteride Revenue by Manufacturers (2021-2026)
- 3.2 Global Finasteride Sales by Manufacturers (2021-2026)
- 3.3 Global Finasteride Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Finasteride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Finasteride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Finasteride Manufacturers, Product Type & Application
- 3.7 Global Finasteride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Finasteride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Finasteride Players Market Share by Revenue in 2025
- 3.8.3 2025 Finasteride Tier 1, Tier 2, and Tier 3
4 Finasteride Market by Type
- 4.1 Finasteride Type Introduction
- 4.1.1 1mg Tablet
- 4.1.2 5mg Tablet
- 4.2 Global Finasteride Sales by Type
- 4.2.1 Global Finasteride Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Finasteride Sales by Type (2021-2032)
- 4.2.3 Global Finasteride Sales Market Share by Type (2021-2032)
- 4.3 Global Finasteride Revenue by Type
- 4.3.1 Global Finasteride Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Finasteride Revenue by Type (2021-2032)
- 4.3.3 Global Finasteride Revenue Market Share by Type (2021-2032)
5 Finasteride Market by Application
- 5.1 Finasteride Application Introduction
- 5.1.1 Medical Uses
- 5.1.2 Application 2
- 5.2 Global Finasteride Sales by Application
- 5.2.1 Global Finasteride Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Finasteride Sales by Application (2021-2032)
- 5.2.3 Global Finasteride Sales Market Share by Application (2021-2032)
- 5.3 Global Finasteride Revenue by Application
- 5.3.1 Global Finasteride Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Finasteride Revenue by Application (2021-2032)
- 5.3.3 Global Finasteride Revenue Market Share by Application (2021-2032)
6 Global Finasteride Sales by Region
- 6.1 Global Finasteride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Finasteride Sales by Region (2021-2032)
- 6.2.1 Global Finasteride Sales by Region (2021-2026)
- 6.2.2 Global Finasteride Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Finasteride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Finasteride Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Finasteride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Finasteride Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Finasteride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Finasteride Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Finasteride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Finasteride Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Finasteride Revenue by Region
- 7.1 Global Finasteride Revenue by Region
- 7.1.1 Global Finasteride Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Finasteride Revenue by Region (2021-2026)
- 7.1.3 Global Finasteride Revenue by Region (2027-2032)
- 7.1.4 Global Finasteride Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Finasteride Revenue (2021-2032)
- 7.2.2 North America Finasteride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Finasteride Revenue (2021-2032)
- 7.3.2 Europe Finasteride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Finasteride Revenue (2021-2032)
- 7.4.2 Asia-Pacific Finasteride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Finasteride Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Finasteride Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceuticals
- 8.1.1 Teva Pharmaceuticals Company Information
- 8.1.2 Teva Pharmaceuticals Business Overview
- 8.1.3 Teva Pharmaceuticals Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceuticals Finasteride Product Portfolio
- 8.1.5 Teva Pharmaceuticals Recent Developments
- 8.2 Sandoz
- 8.2.1 Sandoz Company Information
- 8.2.2 Sandoz Business Overview
- 8.2.3 Sandoz Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sandoz Finasteride Product Portfolio
- 8.2.5 Sandoz Recent Developments
- 8.3 Shandong Renhetang Pharmaceutical
- 8.3.1 Shandong Renhetang Pharmaceutical Company Information
- 8.3.2 Shandong Renhetang Pharmaceutical Business Overview
- 8.3.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio
- 8.3.5 Shandong Renhetang Pharmaceutical Recent Developments
- 8.4 Merck
- 8.4.1 Merck Company Information
- 8.4.2 Merck Business Overview
- 8.4.3 Merck Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck Finasteride Product Portfolio
- 8.4.5 Merck Recent Developments
- 8.5 Zhejiang CONBA Pharmaceutical
- 8.5.1 Zhejiang CONBA Pharmaceutical Company Information
- 8.5.2 Zhejiang CONBA Pharmaceutical Business Overview
- 8.5.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio
- 8.5.5 Zhejiang CONBA Pharmaceutical Recent Developments
- 8.6 Henan Topfond
- 8.6.1 Henan Topfond Company Information
- 8.6.2 Henan Topfond Business Overview
- 8.6.3 Henan Topfond Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Henan Topfond Finasteride Product Portfolio
- 8.6.5 Henan Topfond Recent Developments
- 8.7 Guangdong Eashu Pharmacetical
- 8.7.1 Guangdong Eashu Pharmacetical Company Information
- 8.7.2 Guangdong Eashu Pharmacetical Business Overview
- 8.7.3 Guangdong Eashu Pharmacetical Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio
- 8.7.5 Guangdong Eashu Pharmacetical Recent Developments
- 8.8 RelonChem
- 8.8.1 RelonChem Company Information
- 8.8.2 RelonChem Business Overview
- 8.8.3 RelonChem Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 RelonChem Finasteride Product Portfolio
- 8.8.5 RelonChem Recent Developments
- 8.9 Dr. Reddy
- 8.9.1 Dr. Reddy Company Information
- 8.9.2 Dr. Reddy Business Overview
- 8.9.3 Dr. Reddy Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Dr. Reddy Finasteride Product Portfolio
- 8.9.5 Dr. Reddy Recent Developments
- 8.10 Cipla
- 8.10.1 Cipla Company Information
- 8.10.2 Cipla Business Overview
- 8.10.3 Cipla Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Cipla Finasteride Product Portfolio
- 8.10.5 Cipla Recent Developments
- 8.11 Actavis
- 8.11.1 Actavis Company Information
- 8.11.2 Actavis Business Overview
- 8.11.3 Actavis Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Actavis Finasteride Product Portfolio
- 8.11.5 Actavis Recent Developments
- 8.12 Accord Pharmaceuticals
- 8.12.1 Accord Pharmaceuticals Company Information
- 8.12.2 Accord Pharmaceuticals Business Overview
- 8.12.3 Accord Pharmaceuticals Finasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Accord Pharmaceuticals Finasteride Product Portfolio
- 8.12.5 Accord Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Finasteride Value Chain Analysis
- 9.1.1 Finasteride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Finasteride Production Mode & Process
- 9.2 Finasteride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Finasteride Distributors
- 9.2.3 Finasteride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst